Monthly Archives: January 2009

MedReg Wins the Battles, Loses the War

Posted on January 27, 2009 by Mark Senak

In pharmaceutical companies there is a department called Medical/Regulatory, MedReg for short, that among other things, reviews promotional communications content and form to ensure that it falls within the heavily drawn regulatory parameters outlined by the FDA.  MedReg is made … Continue reading →

Posted in New and Social Media | Comments Off on MedReg Wins the Battles, Loses the War

Morningstar on the Wyeth/Pfizer News

Posted on January 26, 2009 by Mark Senak
Posted in Business/Industry News | Comments Off on Morningstar on the Wyeth/Pfizer News

The Importance of Being Washington – The GAO Outlines FDA Reforms

Posted on January 26, 2009 by Mark Senak

Not the man, the city.   On Sunday, January 25, the Washington Post carried an article entitled "The Height of Power – As Other American Fiefdoms Fade, Washington Looms Larger than Ever."  It was a very interesting article analyzing the current … Continue reading →

Posted in Legislation | Comments Off on The Importance of Being Washington – The GAO Outlines FDA Reforms

Weekly Roundup – 01/23/09

Posted on January 23, 2009 by Mark Senak

Late posting today – Typepad was curiously uncooperative today.   This week we saw the end of one Administration and the beginning of another, but we also saw more than that.  We saw that America once again stood apart from … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup – 01/23/09

The New Acting FDA Commissioner – Frank Torti

Posted on January 22, 2009 by Mark Senak

We have seen the big change with the Inauguration of President Obama.  In our smaller world concerned with the FDA, there has also been significant change.  Dr. Andrew C. von Eschenbach has left the FDA effective January 20, leaving Dr. … Continue reading →

Posted in FDA Image | Comments Off on The New Acting FDA Commissioner – Frank Torti